Co-authored or featuring insights from Prevounce Health co-founder Daniel Tashnek, this article breaks down the latest CMS rulemaking regarding remote patient monitoring (RPM) device costs and what physicians need to report. It highlights regulatory compliance and cost valuation challenges under Medicare guidelines.
Prevounce Health has introduced a new cellular-connected blood glucose meter designed for remote patient monitoring. This product expansion enhances the company's remote care management portfolio and clinical capabilities.
Headlines surfaced and scored by PortcoMonitor. Get the full, ranked feed + a daily briefing →